Injection of Glatiramer Acetate Depot Results in T1 and T2 Lesion Reduction in Relapsing MS.

Published Date: 01 Mar 2023

Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.

Read Full News

Latest News

Top US Psychiatric Hospitals Ranked

Massachusetts General Hospital in Boston is once again the best US hospital for psychiatric care, according to the US News & World Report’s latest ranking of best hospitals for psychiatry.

Favorable Outcomes Follow Previable Membrane Rupture

Most survivors after previable preterm prelabor rupture of membranes show favorable neurodevelopment at 2-3 years, a study suggests.

Wildfire Smoke Linked to Increase in ED Visits for Migraine

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

Large Study Describes Genetic Underpinning of Fibromyalgia

‘This study provides important new insights into why some people develop fibromyalgia syndrome and identifies biological pathways that could lead to new treatment approaches,’ a study co-author says.

FDA Flags Data Concerns About Experimental DMD Therapy

U.S. FDA staff reviewers raised concerns about the effectiveness data for Capricor Therapeutics' cell therapy for a heart condition related ⁠to Duchenne muscular dystrophy,...

Personalized Gene Therapy Promising in Rare Epilepsy

Individualized gene therapies reduce seizures and lead to developmental gains in two boys with severe, treatment-resistant SCN2A-related epilepsy.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

Massachusetts General Hospital in Boston is once again the best US hospital for psychiatric care, according to the US News & World Report’s latest ranking of best hospitals for psychiatry.

Most survivors after previable preterm prelabor rupture of membranes show favorable neurodevelopment at 2-3 years, a study suggests.

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

‘This study provides important new insights into why some people develop fibromyalgia syndrome and identifies biological pathways that could lead to new treatment approaches,’ a study co-author says.

U.S. FDA staff reviewers raised concerns about the effectiveness data for Capricor Therapeutics' cell therapy for a heart condition related ⁠to Duchenne muscular dystrophy,...

Individualized gene therapies reduce seizures and lead to developmental gains in two boys with severe, treatment-resistant SCN2A-related epilepsy.

News All Time

Deep Brain Stimulation Tied to Lower Mortality in PD

Deep brain stimulation is linked to reduced risks for mortality and institutionalization, and lower healthcare costs in adults with Parkinson’s disease, a study shows.

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

What Is Causing This Case of Sudden Aphasia?

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Neuropathy After Recreational Use of Laughing Gas

Clinicians should be aware of adverse effects of this increasingly popular drug

Vitamin C and the Brain; Invisible MS Lesions Revealed; Profound Autism Definition

News and commentary from the world of neurology and neuroscience

Alzheimer's Biomarkers Change After Tuberculosis Vaccination

BCG vaccine altered immune responses and modified amyloid-beta, study shows

Modified Amino Acid Improves Neurologic Symptoms in Rare Genetic Disorder

— Levacetylleucine succeeds in phase III trial of adults and kids with ataxia-telangiectasia

Third Molar Extraction: Benefit or Overtreatment?

Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Brain Risks Tied to High Ultraprocessed Food Intake

Longitudinal study links heavily processed food with a sharp increase in cognitive impairment

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Recommended News For You

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Coffee and tea linked to lower head and neck cancer risk

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

Cancer research in the US is world class. With the government pulling out, its future is uncertain

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Recommended Articles For You

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring 

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell 

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Oncotype Predict Recurrence Risk in Older BC Patients?

2.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

3.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

4.

Children with rare gliomas have new hope thanks to clinical trial results.

5.

An effective treatment for a rare but deadly form of cancer

1.

Transformative Frameworks in Oncology for Better Care

2.

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health

3.

ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy

4.

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options

5.

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

2.

Clinical Insights in Hematology

3.

Understanding the causes of anemia in adults beyond nutritional deficiencies

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot